Alexander's, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Steven Roth
- Full Time Employees
- 103
- Sector
- Real Estate
- Industry
- REIT - Retail
- Address
- 210 Route 4 East Paramus NJ United States of America 07652
- IPO Date
- Feb 21, 1973
- CIK
- 0000003499
- Website
- alx-inc.com
- Similar Companies
- Business
- Alexander's, Inc. (NYSE: ALX) owns, operates and develops retail properties, primarily shopping centers and standalone retail locations anchored by major retailers. The company offers leasing services for retail space; property management and development; and redevelopment of existing assets into mixed-use properties with residential, office and retail components. Its portfolio includes flagship properties such as the Alexander's Building at 731 Lexington Avenue in New York City and Kings Plaza Shopping Center in Brooklyn, New York. Founded in 1955 and headquartered in Paramus, New Jersey, Alexander's primarily serves the New York metropolitan area, with all major properties located in New York State. The company targets national and regional retailers, supermarkets, department stores and entertainment venues as tenants. It operates as a self-administered and self-managed real estate investment trust (REIT) with no subsidiaries or parent company relationships publicly noted. In recent developments, Alexander's continues to focus on strategic property enhancements, including ongoing redevelopment efforts at its 58th Street location in Manhattan to incorporate modern retail and potential residential elements. The company reported stable occupancy rates and rental income growth in its latest quarterly filings amid a resilient retail real estate market. No major acquisitions, partnerships or name changes have been announced in the past 1-2 years.
Alexander's Announces Second Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
Alexander’s Leases 135,000 Square Feet to Target at its Rego Park Shopping Center; Center is 99% Leased
Alexander's Leases 135,000 Square Feet to Target at its Rego Park Shopping Center; Center is 99% Leased
Greenridge Exploration Fully Exercises Option for 100% Interest in the Carpenter Lake Uranium Project in Athabasca Basin, Saskatchewan
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
Alexander’s Completes Sale of Rego Park I
Alexander's Completes Sale of Rego Park I
The Most Hated High Yields On Wall Street
First Look: Aramco profit jump, Nvidia-Corning deal, GM fined
ALX Oncology Q1 Earnings Call Highlights
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
Alexander's (ALX) Q1 FFO and Revenues Lag Estimates
A Look at Alexander's Inc (ALX) After 3.0% Decline -- GF Value $203.84 vs Price $244.34
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Alexander's Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules